A prospective observational study to evaluate a possible relationship between vitamin K antagonist therapy and risk of peripheral arterial disease in patients with type 2 diabetes
Diabetes, Obesity and Metabolism · 2024
DOI: 10.1111/dom.15656 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Diabetes, Obesity and Metabolism, 2024. Verfasst von Olivier Bourron und 5 weiteren Autor:innen. Beteiligte Einrichtung: Sorbonne Université Médecine, Assistance Publique Hôpitaux de Paris (APHP), Diabetology Department, Pitié-Salpêtrière Hospital, INSERM UMRS_1138, Cen…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Peripheral Arterial Disease, Vitamin K, Amputation, Surgical. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Groupement pour l'Etude des Maladies Métaboliques et Systémiques (GEMMS Poitiers, France), Société Francophone du Diabète, Association Française des Diabétiques.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aim
The use of vitamin K antagonists (VKAs) may increase the risk of peripheral arterial disease (PAD) because vitamin K is a strong inhibitor of medial arterial calcification. Type 2 diabetes (T2D) exposes patients to an increased risk of PAD. We examined how the use of VKAs modulates the risk of incident PAD in people with T2D. Materials and Methods SURDIAGENE is a French cohort including 1468 patients with T2D with a prospective follow‐up from 2002 to 2015. The primary outcome of the current analysis was the first occurrence of PAD, a composite of lower‐limb amputation (LLA) or lower‐limb revascularization. LLA and lower‐limb revascularization were considered individually as secondary outcomes.
Results
During a 7‐year median follow‐up, PAD occurred in 147 (10%) of the 1468 participants. The use of VKAs was not significantly associated with the risk of PAD [multivariable adjusted hazard ratio (HR) 1.42, 95% confidence interval (CI), 0.88‐2.31]. During the study period, LLA and lower‐limb revascularization occurred in 82 (6%) and 105 (7%) participants, respectively. The use of VKAs was significantly associated with increased risk of LLA [multivariable adjusted HR 1.90 (95% CI, 1.04‐3.47)], but not lower‐limb revascularization [multivariable adjusted HR 1.08 (95% CI, 0.59‐1.97)].
Conclusions
In this prospective study, we did not observe any excess risk of PAD requiring lower‐limb revascularization in people with type 2 diabetes using VKAs. However, our data suggest a high risk of LLA in VKA users. Further studies are required to confirm this observation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sorbonne Université Médecine, Assistance Publique Hôpitaux de Paris (APHP), Diabetology Department, Pitié-Salpêtrière Hospital, INSERM UMRS_1138, Centre de Recherche des Cordeliers, Institute of Cardiometabolism and Nut…
- Hôpital Haut-Lévêque, Department of Endocrinology, Diabetes and Nutrition, University of Bordeaux, Faculty of Medicine, INSERM unit 1034, Biology of Cardiovascular Diseases, Bordeaux University Hospital, Bordeaux, Franc…
- Centre d'Investigation Clinique CIC1402, Université de Poitiers, CHU de Poitiers, INSERM, Poitiers, France.
- L'institut du Thorax, INSERM, CNRS, UNIV Nantes, Diabetology Department, CHU Nantes, Nantes, France.
ORCID-Profile: Olivier Bourron, Samy Hadjadj
Förderung
- Groupement pour l'Etude des Maladies Métaboliques et Systémiques (GEMMS Poitiers, France)
- Société Francophone du Diabète
- Association Française des Diabétiques
- French Ministry of Health
Zitieren
APA
Bourron, O., Mohammedi, K., De Keizer, J., Schneider, F., Hadjadj, S., & Saulnier, P. J. (2024). A prospective observational study to evaluate a possible relationship between vitamin K antagonist therapy and risk of peripheral arterial disease in patients with type 2 diabetes. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.15656
Vancouver
Bourron O, Mohammedi K, De Keizer J, Schneider F, Hadjadj S, Saulnier PJ. A prospective observational study to evaluate a possible relationship between vitamin K antagonist therapy and risk of peripheral arterial disease in patients with type 2 diabetes. Diabetes, Obesity and Metabolism. 2024. doi:10.1111/dom.15656
BibTeX
@article{Bourron2024,
author = {Bourron, Olivier and Mohammedi, Kamel and De Keizer, Joe and Schneider, Fabrice and Hadjadj, Samy and Saulnier, Pierre-Jean},
title = {A prospective observational study to evaluate a possible relationship between vitamin K antagonist therapy and risk of peripheral arterial disease in patients with type 2 diabetes},
journal = {Diabetes, Obesity and Metabolism},
year = {2024},
doi = {10.1111/dom.15656}
}
EUVIMED